Interstitial Lung Disease

Interstitial Lung Disease Causes

Interstitial lung disease causes

Interstitial Lung Disease Causes

Interstitial lung disease is a group of diverse pulmonary conditions that have a variety of causes. The common thread is that each condition is associated with lung tissue damage. This damage results from an abnormal healing response in the form of excessive scar tissue production. Specifically, the body’s natural repair process goes awry, causing the air sacs within the lungs (alveoli) to thicken. This can make it difficult to breathe and slow the flow of oxygen from the lungs to the blood.

Interstitial lung disease can be triggered by many factors. Some known causes include:

  • Inhalation of asbestos fibers, grain dust, coal dust, silica dust, mold or bird proteins (from live pets or feather-containing products)
  • Certain chemotherapy or immunotherapy drugs (methotrexate and cyclophosphamide), heart medications (amiodarone and propranolol) or antibiotics (nitrofurantoin and sulfasalazine)
  • Radiation therapy administered to the chest
  • Certain autoimmune conditions, including dermatomyositis, mixed connective tissue disease, pulmonary vasculitis, rheumatoid arthritis, sarcoidosis, scleroderma, Sjogren’s syndrome and lupus

Once lung scarring occurs, it cannot be reversed. Certain medications can ease the symptoms of interstitial lung disease, such as dry coughing and shortness of breath, but pharmaceutical treatments cannot restore lost lung function. Supplemental oxygen can also be helpful for symptom relief, but its round-the-clock usage can be cumbersome. If a patient has very severe or worsening symptoms, a lung transplant may be an option. However, for some patients, none of these options is ideal.

The Lung Institute offers stem cell therapy as an alternative treatment for interstitial lung disease. Stem cells, which are produced naturally by the body, have the remarkable ability to transform themselves into many other types of cells. As such, they have the potential to promote the healing of damaged tissue. We offer two main types of autologous stem cell therapy: bone marrow and venous (blood). Both procedures are minimally invasive and performed on an outpatient basis over the course of two days.

If your dissatisfaction with traditional treatments for interstitial lung disease causes you to search for other options, contact the Lung Institute at (800) 729-3065. Our caring team can explain how stem cell therapy can potentially help you breathe easier and get back to living life to the fullest.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.